- Home
- ACNT vs ELDN Comparison
ACNT vs ELDN Comparison
Compare ACNT & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACNT | ELDN |
|---|---|---|
| Founded | 1945 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.0M | 208.6M |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ACNT | ELDN |
|---|---|---|
| Price | $12.79 | $2.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 125.5K | ★ 913.4K |
| Earning Date | 06-15-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 106.72 | 54.27 |
| EPS | ★ 0.09 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $143.44 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.62 | $1.35 |
| 52 Week High | $17.92 | $4.60 |
Technical Indicators
Market Signals| Indicator | ACNT | ELDN |
|---|---|---|
| Relative Strength Index (RSI) | 20.15 | 57.17 |
| Support Level | $12.08 | $2.48 |
| Resistance Level | $13.06 | $2.77 |
| Average True Range (ATR) | 0.60 | 0.21 |
| MACD | -0.44 | 0.01 |
| Stochastic Oscillator | 5.81 | 43.85 |
Price Performance
Historical ComparisonAbout ACNT Ascent Industries Co.
Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.